Get started
Author

Liesbeth Bieghs

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
2016 · Liesbeth Bieghs, Hans E. Johnsen, et al. · Oncotarget · 62
PDF
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
2014 · Liesbeth Bieghs, Susanne Lub, et al. · Oncotarget · 19
PDF
Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients
2016 · Liesbeth Bieghs, Malene Brohus, et al. · PLoS ONE · 15
PDF
The Effects of Forodesine in Murine and Human Multiple Myeloma Cells
2010 · Liesbeth Bieghs, Jo Caers, et al. · Advances in Hematology · 5
PDF
The IGF system in multiple myeloma: exploring diagnostic and therapeutic potential
2014 · Liesbeth Bieghs
The IGF-1 receptor inhbitor picropodophyllin (PPP) potentiates the anti-myeloma effects of the BH3 mimetic ABT-737.
2013 · Liesbeth Bieghs · VUBIR (Vrije Universiteit Brussel)
Combination of the IGF-1 Receptor Inhibitor Picropodophylin and the BH3 Mimetic ABT-737 Has Synergistic Anti-Myeloma Activity
2012 · Liesbeth Bieghs, Ken Maes, et al. · Blood
P01-24 The combination of the IGF-1 receptor inhibitor picropodophylin (PPP) and the BH3 mimetic ABT-737 has synergistic anti-myeloma activity
2012 · L. Bieghs, K. Maes, et al. · Growth Hormone & IGF Research
The synergistic anti-myeloma effects of the BH3 mimetic ABT-737 and the IGF-1 receptor inhibitor picropodophylin (PPP).
2012 · Bieghs, Liesbeth, van Valckenborgh, E., et al.
Synergistic anti-myeloma effects of the IGF-1 receptor inhibitor picropodophylin and the BH3 mimetic ABT-737
2012 · Elke De Bruyne, Liesbeth Bieghs, et al.
Works count: 11
Citation count: 101
H-index: 4
I10-index: 3
Year
Topic
Type